A novel hSCARB2 knock-in mouse model successfully replicated the clinical pathology and neurotoxicity of CVA16 infection, exhibiting prominent limb weakness and paralysis.
A newly developed hSCARB2 knock-in mouse model successfully replicates the neuropathological changes and neurotoxicity induced by CVA16 infection, providing a reliable platform for future pathogenesis research.
Hand, Foot, and Mouth Disease (HFMD) is a viral illness caused by enterovirus infections. While the introduction of the enterovirus 71 (EV71) vaccine has significantly reduced the number of EV71-related cases, the continued spread of Coxsackievirus A16 (CVA16) remains a major public health threat. Previous studies have shown that human SCARB2 (hSCARB2) knock-in (KI) mice, generated using embryonic stem cell (ESC) technology, are susceptible to CVA16. However, these models have failed to reproduce the clinical pathology and neurotoxicity after CVA16 infection. Therefore, there is an urgent need for a more reliable and effective animal model to study CVA16. In this study, we successfully created a hSCARB2 KI mouse model targeting the ROSA26 locus using CRISPR/Cas9 gene editing technology. The application of CRISPR/Cas9 enabled stable and widespread expression of hSCARB2 in the model. After infection, the KI mice exhibited a clinical pathology that closely mimics human infection, with prominent limb weakness and paralysis. The virus was detectable in multiple major organs of the mice, with peak viral load observed on day 7 post-infection, gradually clearing thereafter. Further analysis revealed widespread neuronal necrosis and infiltration of inflammatory cells in the brain and spinal cord of the KI mice. Additionally, significant activation of astrocytes (GFAP-positive) and microglia (IBA1-positive) was observed in the brain, suggesting that CVA16 infection may induce limb paralysis by attacking neuronal cells. Overall, this model effectively replicates the neuropathological changes induced by CVA16 infection and provides a potential experimental platform for studying CVA16-associated pathogenesis and neurotoxicity.
Wu et al. (Fri,) conducted a other in Coxsackievirus A16 (CVA16) infection. hSCARB2 knock-in mouse model was evaluated on Clinical pathology and neurotoxicity. A novel hSCARB2 knock-in mouse model successfully replicated the clinical pathology and neurotoxicity of CVA16 infection, exhibiting prominent limb weakness and paralysis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: